Side effects of oral misoprostol for the prevention of postpartum hemorrhage: Results of a community-based randomised controlled trial in rural India
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Shobhana S. Patted MD, DNB, DGO, DICOG, FICOGa*, Shivaprasad S. Goudarb, Vijaya A. Naikc, Mrutyunjaya B. Bellada, Stanley A. Edlavitchd, Bhalchandra S. Kodkanye, Ashlesha Patelf, Hrishikesh Chakrabortyg, Richard J. Dermanhi & Stacie E. Gellerjka Department of Obstetrics and Gynecology, Jawaharal Nehru Medical College, Belgaum, Indiab Department of Physiology, Jawaharal Nehru Medical College, Belgaum, Indiac Department of Community Medicine, Jawaharal Nehru Medical College, Belgaum, Indiad Department of Epidemiology and Informatics, University of Missouri Kansas City, Kansas City, MO, USAe Jawaharal Nehru Medical College, Belgaum, Indiaf John H. Stroger Jr. Hospital of Cook County, Chicago, IL, USAg Research Triangle Institute (RTI) International, Research Triangle Park, NC, USAh Jefferson Medical College, Philadelphia, PA, USAi Christiana Care, Newark, DE, USAj Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL, USAk Center for Research on Women and Gender, University of Illinois at Chicago, Chicago, IL, USA† Correspondence: Shobhana S. Patted, Department of Obstetrics and Gynecology, K.L.E.S' University, Belgaum, 590 010, India, +91 0831 2455030, +91 0831 2470759 [email protected]. To investigate the side effects of 600 μg oral misoprostol given for the mother and the newborn to prevent postpartum hemorrhage (PPH).Methods. One thousand six hundred twenty women delivering at home or subcentres in rural India were randomised to receive misoprostol or placebo in the third stage of labour. Women were evaluated for shivering, fever, nausea, vomiting and diarrhea at 2 and 24 h postpartum. Newborns were evaluated within 24 h for diarrhea, vomiting and fever. Symptoms were graded as absent, mild-to-moderate or severe.Results. Women who received misoprostol had a significantly greater incidence of shivering (52%vs. 17%, p < 0.001) and fever (4.2%vs. 1.1%, p < 0.001) at 2 h postpartum compared with women who received placebo. At 24 h, women in the misoprostol group experienced significantly more shivering (4.6%vs. 1.4%, p < 0.001) and fever (1.4%vs. 0.4%, p < 0.03). There were no differences in nausea, vomiting or diarrhea between the two groups. There were no differences in the incidence of vomiting, diarrhea or fever for newborns.Conclusions. Misoprostol is associated with a significant increase in postpartum maternal shivering and fever with no side effects for the newborn. Given its proven efficacy for the prevention of PPH, the benefits of misoprostol are greater than the associated risks.
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2167091097